{{Distinguish|nitrazepam}}
{{Drugbox
| IUPAC_name = 1-methyl-8-nitro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
| image = Nitrazolam.svg
| width =

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| pregnancy_category = 
| legal_CA = Schedule IV
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref =
| CAS_number = 28910-99-8
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 20317278
| ChemSpiderID = 15387105
| UNII = K499DBB308

<!--Chemical data-->
| C=17 | H=13 | N=5 | O=2
| molecular_weight =
| melting_point =
| smiles = Cc1nnc2CN=C(c3ccccc3)c4cc(ccc4n12)[N+]([O-])=O
| StdInChI = 1S/C17H13N5O2/c1-11-19-20-16-10-18-17(12-5-3-2-4-6-12)14-9-13(22(23)24)7-8-15(14)21(11)16/h2-9H,10H2,1H3
| StdInChIKey = OYRPNABWTHDOFK-UHFFFAOYSA-N
}}

'''Nitrazolam''' is a [[benzodiazepine]]<ref>{{cite web | url=http://www.google.com/patents/US3987052 | title=Patent US3987052 - 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines | publisher=The Upjohn Company | date=19 October 1976 | author=Jackson B. Hester, Jr}}</ref> that has been sold online as a [[designer drug]].<ref>{{cite web | url=http://nsddb.eu/substance/574/ | title=Nitrazolam | publisher=New Synthetic Drugs Database}}</ref><ref>{{cite journal|first1=Bjoern|last1=Moosmann|first2=Philippe|last2=Bisel|first3=Florian|last3=Franz|first4=Laura M.|last4=Huppertz|title=Characterization and ''in vitro'' phase I microsomal metabolism of designer benzodiazepines – an update comprising adinazolam, cloniprazepam, fonazepam, 3-hydroxyphenazepam, metizolam, and nitrazolam|url=http://onlinelibrary.wiley.com/doi/10.1002/jms.3840/abstract|journal=Journal of Mass Spectrometry|date=2016|issn=1096-9888|volume=51|issue=|pages=1080–1089|via=Wiley Online Library|doi=10.1002/jms.3840|pmid=27535017|first5=Volker|last5=Auwärter}}</ref>

It is closely related to [[clonazolam]], only differing by the removal of a chlorine group at the benzene ring.

Animal studies indicate that nitrazolam can be several times more potent than [[diazepam]] as an antagonist of electroshock-induced tonic-extensor convulsions.<ref>{{cite journal | url=http://pubs.acs.org/doi/abs/10.1021/jm00293a015 | title=6-Phenyl-4H-s-triazolo[4,3-a] [1,4]benzodiazepines which have central nervous system depressant activity |author1=Jackson B. Hester Jr. |author2=Allan D. Rudzik |author3=Bharat V. Kamdar | journal=Journal of Medicinal Chemistry |date=November 1971  | volume=14 | issue=11 | pages=1078–1081 | doi=10.1021/jm00293a015 | pmid=5165540}}</ref>

== Legal Status ==

=== United Kingdom ===
In the UK, nitrazolam has been classified as a [[Drugs controlled by the UK Misuse of Drugs Act|Class C drug]] by the May 2017 amendment to [[Misuse of Drugs Act 1971|The Misuse of Drugs Act 1971]] along with several other designer benzodiazepine drugs.<ref>{{Cite web|url=http://www.legislation.gov.uk/uksi/2017/634/contents/made|title=The Misuse of Drugs Act 1971 (Amendment) Order 2017|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>

==See also==
{{Colbegin}}
* [[Adinazolam]]
* [[Alprazolam]] (licensed)
* [[Flubromazolam]]
* [[Pyrazolam]]
* [[Triazolam]] (licensed)
{{Colend}}

==References==
{{reflist}}

{{Benzodiazepines}}
{{Hypnotics and sedatives}}
{{GABAAR PAMs}}

[[Category:Benzodiazepines]]
[[Category:Designer drugs]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Triazolobenzodiazepines]]


{{sedative-stub}}